Massimo Montano

Head And Neck Oncology Unit
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Neoadjuvant Immunotherapy in Head and Neck Cancers: A Paradigm Shift in Treatment Approach.

Neoadjuvant Immunotherapy in Head and Neck Cancers: A Paradigm Shift in Treatment Approach.

Journal: Biomedicines
Published: September 24, 2024

Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era?

Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era?

Journal: Cancers
Published: January 24, 2024

Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer.

Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer.

Journal: Cancers
Published: February 09, 2023

Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.

Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.

Journal: Anti-cancer drugs
Published: February 20, 2019

Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: Outcome analysis in 93 patients treated in a single institution.

Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: Outcome analysis in 93 patients treated in a single institution.

Journal: Oral oncology
Published: December 07, 2018

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.

Journal: BMC cancer
Published: December 23, 2015

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).

Journal: Cancer
Published: August 11, 2015

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.

Journal: World journal of gastroenterology
Published: December 16, 2013

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Journal: BMC cancer
Published: October 10, 2013

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

Journal: Anti-cancer agents in medicinal chemistry
Published: November 26, 2012

Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.

Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 22, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026